Shalby Ltd (SHAY)

Currency in INR
254.85
+2.80(+1.11%)
Closed·
SHAY Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected in 7 days
SHAY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
249.35257.70
52 wk Range
177.25274.70
Key Statistics
Bid/Ask
253.20 / 254.85
Prev. Close
254.85
Open
249.55
Day's Range
249.35-257.7
52 wk Range
177.25-274.7
Volume
235.31K
Average Volume (3m)
839.52K
1-Year Change
-3.28%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SHAY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Shalby Ltd Company Profile

Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neurology, ideal stroke treatment, epilepsy, endovascular/interventional neurosurgery, and trans cranial doppler; obstetrics and gynaecology; surgical oncology, medical oncology, radiation oncology, bone marrow transplant, onco-psychology, onco-dietetics, onco-physiotherapy, and home care; ophthalmology; paediatrics; pathology and microbiology; psychiatry; pulmonology and chest; and interventional and diagnostic radiology. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is based in Ahmedabad, India.

Employees
2592
Market
India

Compare SHAY to Peers and Sector

Metrics to compare
SHAY
Peers
Sector
Relationship
P/E Ratio
−5,325.7x49.5x−0.7x
PEG Ratio
52.951.360.00
Price/Book
2.8x8.7x2.6x
Price / LTM Sales
2.5x6.3x3.4x
Upside (Analyst Target)
21.6%8.8%37.8%
Fair Value Upside
Unlock−12.1%5.5%Unlock

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
0.71 / --
Revenue / Forecast
2.96B / --
EPS Revisions
Last 90 days

SHAY Income Statement

People Also Watch

154.43
ADAN
+3.16%
3,889.50
NETE
-3.43%
132.51
SAIL
+0.26%

FAQ

What Stock Exchange Does Shalby Trade On?

Shalby is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Shalby?

The stock symbol for Shalby is "SHAY."

What Is the Shalby Market Cap?

As of today, Shalby market cap is 27.37B.

What Is Shalby's Earnings Per Share (TTM)?

The Shalby EPS (TTM) is -0.04.

When Is the Next Shalby Earnings Date?

Shalby will release its next earnings report on 20 Oct 2025.

From a Technical Analysis Perspective, Is SHAY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Shalby Stock Split?

Shalby has split 0 times.

How Many Employees Does Shalby Have?

Shalby has 2592 employees.

What is the current trading status of Shalby (SHAY)?

As of 14 Oct 2025, Shalby (SHAY) is trading at a price of 254.85, with a previous close of 254.85. The stock has fluctuated within a day range of 249.35 to 257.70, while its 52-week range spans from 177.25 to 274.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.